The EFF Spring Virtual Summit will be a virtual meeting featuring the latest data from the ProQR QR-421a Stellar study, a phase 1b/2 study in USH2A mediated syndrome and retinitis pigmentosa, as well as a panel discussion with expert perspectives from the clinical and patient community.
We are pleased to announce Dr. Paul Yang, Krista Vasi and Mani Iyer will join as special guests, participating in the discussions and will be answering questions from the audience.
Presented by: Daniel de Boer, CEO, ProQR Therapeutics
Time: 17:00 CET / 11:00 EST
Daniel de Boer will open the EFF Spring Virtual Summit.
Presented by: Aniz Girach, Chief Medical Officer, ProQR Therapeutics
Time: 17:05 CET / 11:05 EST
Aniz Girach, CMO ProQR, will present a short update on the status of the ProQR Usher syndrome program, including the outcome from the recent clinical milestone.
For a more detailed presentation on the recent Stellar clinical trial results of the QR-421a program for USH2A mediated Usher syndrome and retinitis pigmentosa, please watch (listen to) the video below.
On our YouTube channel you can navigate through the video using the timestamp links in the description.
Dr. Paul Yang, Krista Vasi and Mani Iyer have been invited to the panel discussion on Usher syndrome clinical trials and the IRD community to answer all the questions the audience may have. What is the current state of clinical research in Usher syndrome? What is the patients’ perspective on current clinical research?
Make sure to pre-submit all your questions here!
Speaker: Jennifer Pluim
Time: 18:25 CET / 12:25 EST
If you would like to join the EFF Spring Virtual Summit 2021, please subscribe to get the webinar details and regular updates on EFF events:
Find out practical information about the event.